{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:14:17Z","timestamp":1788527657278,"version":"build-2803163510"},"reference-count":52,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Blood donation sustains an estimated 118 million annual donations worldwide, and while advances in infectious disease screening have greatly reduced recipient risk, the long-term health of repeat donors has received comparatively less attention. This cumulative review synthesises current evidence on the principal acquired complications of regular blood donation across all modalities\u2014whole blood, plasmapheresis, and plateletpheresis\u2014addressing iron deficiency, plasma protein depletion, apheresis-related lymphopenia, clonal haematopoiesis of indeterminate potential (CHIP), and micronutrient deficiency. Iron deficiency affects 15\u201336% of frequent whole blood donors and is systematically underdetected by haemoglobin-based screening alone; ferritin-guided interval adjustment and oral supplementation are effective countermeasures. Regular plasmapheresis depletes immunoglobulins (IgG below normal in 5\u201315% of high-frequency donors), albumin, and coagulation factors, compounded by cumulative citrate-mediated hypocalcaemia. Plateletpheresis causes measurable subset-selective T-cell and NK-cell depletion, with CD4+ counts below clinically significant thresholds in a minority of the most frequent donors, an observation of unknown significance. Emerging molecular data indicate that repeated haematopoietic stress selectively enriches low-risk, EPO-responsive DNMT3A clonal variants without increasing malignant risk. Regular blood donation if properly applied is a safe process. Across all domains, current eligibility criteria based on haemoglobin alone turn out to be inadequate; a shift to multiparameter, individualised and targeted donor monitoring\u2014integrating ferritin, serum proteins, differential leucocyte counts, and micronutrient profiling\u2014is both evidence-suggested and ethically worth considering to sustain the long-term health of voluntary donor populations.<\/jats:p>","DOI":"10.3390\/jcm15176847","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:20:46Z","timestamp":1788524446000},"page":"6847","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential Health Consequences of Regular Blood Donation: Current Evidence and Remaining Uncertainties"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-9675","authenticated-orcid":false,"given":"Sarah","family":"Berli","sequence":"first","affiliation":[{"name":"Blood Transfusion Service SRC Zurich, Swiss Red Cross, CH-8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara Sofie","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Blood Transfusion Service SRC Zurich, Swiss Red Cross, CH-8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em\u00e9ry","family":"Schindler","sequence":"additional","affiliation":[{"name":"Blood Transfusion Service SRC Zurich, Swiss Red Cross, CH-8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3135-4630","authenticated-orcid":false,"given":"Dimitrios A.","family":"Tsakiris","sequence":"additional","affiliation":[{"name":"Blood Transfusion Service SRC Zurich, Swiss Red Cross, CH-8952 Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MOH.0b013e32836589f2","article-title":"Blood donor iron status: Are we bleeding them dry?","volume":"20","author":"Spencer","year":"2013","journal-title":"Curr. Opin. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOH.0000000000000733","article-title":"Iron status of blood donors","volume":"29","author":"Spencer","year":"2022","journal-title":"Curr. Opin. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1537-2995.2011.03401.x","article-title":"Iron deficiency in blood donors: The REDS-II Donor Iron Status Evaluation (RISE) study","volume":"52","author":"Cable","year":"2012","journal-title":"Transfusion"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/S0140-6736(17)31928-1","article-title":"Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): A randomised trial of 45,000 donors","volume":"390","author":"Thompson","year":"2017","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2352-3026(19)30106-1","article-title":"Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): Extension study of a randomised trial of 20,757 blood donors","volume":"6","author":"Kaptoge","year":"2019","journal-title":"Lancet Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/vox.13639","article-title":"Iron status in Dutch and Finnish blood donor and general populations: A cross-cohort comparison study","volume":"119","author":"Karregat","year":"2024","journal-title":"Vox Sang."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(24)01085-7","article-title":"Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND\u2019EM): A stepped-wedge cluster-randomised trial","volume":"404","author":"Meulenbeld","year":"2024","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e194442","DOI":"10.1172\/jci.insight.194442","article-title":"Effects of iron repletion on brain iron content, myelination, neural network activation, and cognition","volume":"10","author":"Hod","year":"2025","journal-title":"JCI Insight"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Pothast, M., Paalvast, Y., van den Hurk, K., and Janssen, M. (Transfusion, 2026). A ferritin prediction model to determine individual blood donation frequencies, Transfusion, ahead of print.","DOI":"10.1111\/trf.70303"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000446817","article-title":"Generalizability of Dutch Prediction Models for Low Hemoglobin Deferral: A Study on External Validation and Updating in Swiss Whole Blood Donors","volume":"43","author":"Baart","year":"2016","journal-title":"Transfus. Med. Hemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jama.2015.119","article-title":"Oral iron supplementation after blood donation: A randomized clinical trial","volume":"313","author":"Kiss","year":"2015","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"150950","DOI":"10.1016\/j.tmrv.2025.150950","article-title":"Knowledge Related to Blood Donation and Iron, and Willingness to Take Iron Supplements Among Blood Donors in Multiple Countries","volume":"40","author":"Krommendijk","year":"2026","journal-title":"Transfus. Med. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/vox.13512","article-title":"A donor safety evidence literature review of the short- and long-term effects of plasmapheresis","volume":"119","author":"Hoad","year":"2024","journal-title":"Vox Sang."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000522528","article-title":"Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study","volume":"49","author":"Moog","year":"2022","journal-title":"Transfus. Med. Hemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1423-0410.2006.00794.x","article-title":"A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA)","volume":"91","author":"Schulzki","year":"2006","journal-title":"Vox Sang."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.0042-9007.2004.00408.x","article-title":"The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers","volume":"86","author":"Storch","year":"2004","journal-title":"Vox Sang."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1046\/j.1537-2995.1998.381098440858.x","article-title":"Frequency of immediate adverse effects associated with apheresis donation","volume":"38","author":"McLeod","year":"1998","journal-title":"Transfusion"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1046\/j.1537-2995.2001.41091165.x","article-title":"Comprehensive analysis of citrate effects during plateletpheresis in normal donors","volume":"41","author":"Bolan","year":"2001","journal-title":"Transfusion"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"150851","DOI":"10.1016\/j.tmrv.2024.150851","article-title":"Balancing Donor Health and Plasma Collection: A Systematic Review of the Impact of Plasmapheresis Frequency","volume":"38","author":"Schroyens","year":"2024","journal-title":"Transfus. Med. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1182\/blood-2018-09-873125","article-title":"Plateletpheresis-associated lymphopenia in frequent platelet donors","volume":"133","author":"Gansner","year":"2019","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2257.1985.tb00029.x","article-title":"Lymphocytopenia in donors undergoing regular platelet apheresis with cell separators","volume":"7","author":"Robbins","year":"1985","journal-title":"Clin. Lab. Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1111\/trf.15441","article-title":"Severe CD4+ T-cell lymphopenia is not observed in frequent plateletpheresis donors collected on the Fenwal Amicus","volume":"59","author":"Gansner","year":"2019","journal-title":"Transfusion"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/trf.17567","article-title":"Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative study","volume":"63","author":"Kaufman","year":"2023","journal-title":"Transfusion"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/trf.16175","article-title":"Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study","volume":"61","author":"Zhao","year":"2021","journal-title":"Transfusion"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/trf.15192","article-title":"CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year","volume":"59","author":"Rahmani","year":"2019","journal-title":"Transfusion"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/trf.17037","article-title":"COVID-19 vaccine humoral response in frequent platelet donors with plateletpheresis-associated lymphopenia","volume":"62","author":"Laumaea","year":"2022","journal-title":"Transfusion"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e180065","DOI":"10.1172\/JCI180065","article-title":"Clonal hematopoiesis and hematological malignancy","volume":"134","author":"Dunn","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.20517\/jca.2023.39","article-title":"Regulators of clonal hematopoiesis and physiological consequences of this condition","volume":"4","author":"Park","year":"2024","journal-title":"J. Cardiovasc. Aging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.2024027999","article-title":"Clonal hematopoiesis landscape in frequent blood donors","volume":"145","author":"Karpova","year":"2025","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1111\/trf.16020","article-title":"Risk of hematological malignancy in blood donors: A nationwide cohort study","volume":"60","author":"Zhao","year":"2020","journal-title":"Transfusion"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOH.0000000000000688","article-title":"Clonal hematopoiesis driven by DNMT3A and TET2 mutations: Role in monocyte and macrophage biology and atherosclerotic cardiovascular disease","volume":"29","author":"Cobo","year":"2022","journal-title":"Curr. Opin. Hematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/hematology.2023000483","article-title":"Clonal hematopoiesis in frequent whole blood donors","volume":"2023","author":"Karpova","year":"2023","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood-2017-07-794362","article-title":"Clonality in context: Hematopoietic clones in their marrow environment","volume":"130","author":"Cooper","year":"2017","journal-title":"Blood"},{"key":"ref_37","first-page":"457","article-title":"CHIP ahoy: Charting a decade of discovery in clonal hematopoiesis","volume":"111","author":"Wong","year":"2026","journal-title":"Haematologica"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1200\/JCO.21.02286","article-title":"Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation","volume":"40","author":"Gibson","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/07315724.1987.10720207","article-title":"Vitamin status in patients undergoing single or multiple plasmapheresis","volume":"6","author":"Reddi","year":"1987","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/vox.70105","article-title":"The effect of plasma donation frequency on total serum protein, immunoglobulin G and donor safety: A non-inferiority randomized controlled trial","volume":"120","author":"Haugen","year":"2025","journal-title":"Vox Sang."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1079\/PHN2001159","article-title":"MTHFR gene polymorphism, homocysteine and cardiovascular disease","volume":"4","author":"Cortese","year":"2001","journal-title":"Public Health Nutr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.numecd.2011.10.001","article-title":"Folate, vitamin B12 and homocysteine status in an Italian blood donor population","volume":"23","author":"Zappacosta","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(01)00745-6","article-title":"Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: A randomised controlled trial in Italian smoker-blood donors","volume":"163","author":"Cafolla","year":"2002","journal-title":"Atherosclerosis"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"104143","DOI":"10.1016\/j.transci.2025.104143","article-title":"Considerations on the number of plasma donations per donor per year: Pro","volume":"64","author":"Moog","year":"2025","journal-title":"Transfus. Apher. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/trf.17523","article-title":"Effects of donation frequency on U.S. source plasma donor health","volume":"63","author":"Fransen","year":"2023","journal-title":"Transfusion"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e18589","DOI":"10.7717\/peerj.18589","article-title":"Correlation and mediation analysis between plasmapheresis donation behavior and bone mineral density and bone metabolism biomarkers: A cross-sectional study based on plasmapheresis donors at high risk of osteoporosis in China","volume":"12","author":"Li","year":"2024","journal-title":"PeerJ"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"104142","DOI":"10.1016\/j.transci.2025.104142","article-title":"Considerations on the number of plasma donations per donor per year: Con","volume":"64","author":"Vrielink","year":"2025","journal-title":"Transfus. Apher. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1070808","DOI":"10.3389\/fnut.2023.1070808","article-title":"Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants","volume":"10","author":"Cui","year":"2023","journal-title":"Front. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1111\/trf.12047","article-title":"Development of a riboflavin and ultraviolet light-based device to treat whole blood","volume":"53","author":"Reddy","year":"2013","journal-title":"Transfusion"},{"key":"ref_50","first-page":"357","article-title":"Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology","volume":"15","author":"Yonemura","year":"2017","journal-title":"Blood Transfus."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/vox.13541","article-title":"Physiological and psychological stress response of blood donors during the blood donation process","volume":"118","author":"Kaur","year":"2023","journal-title":"Vox Sang."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000517566","article-title":"A Cross-Sectional Study of Blood Donors\u2019 Psychological Characteristics over 8 Weeks","volume":"49","author":"Esefeld","year":"2022","journal-title":"Transfus. Med. Hemother."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6847\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:24:49Z","timestamp":1788524689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":52,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176847"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176847","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}